S. Heeger

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier et al. · European Journal of Cancer · 2012 · 591 citations

Gastrointestinal Oncology, Medicine, Pharmacology +9

Use of Early Tumor Shrinkage to Predict Long-Term Outcome in Metastatic Colorectal Cancer Treated With Cetuximab

Hubert Piessevaux, Marc Buyse, Michael Schlichting et al. · Journal of Clinical Oncology · 2013 · 221 citations · Full text

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Stephanie E. Combs, S. Heeger, Renate Haselmann et al. · BMC Cancer · 2006 · 96 citations · Full text

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

Ralf‐Dieter Hofheinz, Karoline Horisberger, Christoph M. Woernle et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 94 citations

Surgical Oncology, Radiation Therapy, Neoadjuvant Therapy +10

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.

G. Hartung, G. Stehle, H. Sinn et al. · PubMed · 1999 · 89 citations

Cancer Management, German Cancer Society, Pharmacotherapy +18